POSC7 Work Productivity and Activity Impairment for Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Phase 3 Trials (CIMPASI-1 AND CIMPASI-2)
Abstract
Authors
D Thaçi J Bagel J Węgłowska V Piguet N Tilt JM López Pinto S Kiri AB Gottlieb